Biocon reported a consolidated net profit of Rs.92.81 crore during the third quarter ended December 31, 2012, up 9.38 per cent when compared with the corresponding quarter of the previous year. Total revenues were higher by 23.63 per cent at Rs.625 crore. While the pharma business contributed Rs.501 crore to revenues, up 23 per cent on an annualised, that from contract research and manufacturing increased by 21 per cent to Rs.146 crore.

Keywords: Biocon

More In: Companies | Business